We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+15.86%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$241M
AUM Growth
+$16.7M
Cap. Flow
-$25.8M
Cap. Flow %
-10.72%
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
1
Reduced
–
Closed
5

Top Buys

Rank Stock Value
1
LJPC
La Jolla Pharmaceutical Company
LJPC
+$2.62M
2
BGMS
Bio Green Med Solution Inc
BGMS
+$1.99M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$4.77M
2
NKTR icon
Nektar Therapeutics
NKTR
+$3.7M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$1.22M
4
LPCN icon
Lipocine
LPCN
+$790K
5
CLDX icon
Celldex Therapeutics
CLDX
+$220K

Sector Composition

Rank Sector Weight
1 Healthcare 90.86%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$107M 44.29%
6,197,198
– –
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$75.9M 31.49%
3,191,165
+139,035
+5% +$2.62M
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
$25M 10.36%
3,972,800
– –
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.35M 3.46%
90,215
– –
BGMS
5
Bio Green Med Solution Inc
BGMS
$5.05M
$2.16M 0.9%
+5
New +$1.99M
ATYR
6
aTyr Pharma
ATYR
$46.4M
$889K 0.37%
19,959
– –
BABA icon
7
Alibaba
BABA
$269B
– –
-60,000
Closed -$4.77M
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.37B
– –
-430,000
Closed -$1.22M
CLDX icon
9
Celldex Therapeutics
CLDX
$2.77B
– –
-3,333
Closed -$220K
LPCN icon
10
Lipocine
LPCN
$17.1M
– –
-15,294
Closed -$790K
NKTR icon
11
Nektar Therapeutics
NKTR
$2.39B
– –
-17,333
Closed -$3.7M

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Tang Capital Management held 12 positions worth $241M, up 7.4% from $224M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management withdrew a net $25.8M in Q3 2016, closing 5 positions. Its most notable exit was Alibaba, an estimated $4.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 87% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Tang Capital Management opened a new position in Bio Green Med Solution Inc worth $2.16M.

  • Tang Capital Management's largest Q3 2016 buy was Bio Green Med Solution Inc: 5 shares worth $2.16M.
  • Tang Capital Management added most to La Jolla Pharmaceutical Company in Q3 2016, an estimated $2.62M increase.
  • Tang Capital Management fully exited Alibaba in Q3 2016, selling an estimated $4.77M.
  • Tang Capital Management's ten largest holdings make up 100% of its $241M portfolio in Q3 2016.
  • Tang Capital Management opened 1 new position and closed 5 in Q3 2016.
  • Tang Capital Management's portfolio value rose 7.4% quarter-over-quarter to $241M.

Based on Tang Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.